Unilever shares rise as it rules out increasing its £50bn consumer healthcare takeover offer to GSK

Shares in consumer goods giant Unilever have risen after it effectively ended its pursuit of GlaxoSmithKline's consumer healthcare business saying it would not raise its £50bn offer.